Anti-cancer therapies targeting the tumor stroma Valeska HofmeisterDavid SchramaJürgen C. Becker Review 27 July 2007 Pages: 1 - 17
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects Diana LlopizJavier DotorPablo Sarobe Original Article 13 June 2007 Pages: 19 - 29
Immunological profiling of a panel of human ovarian cancer cell lines Tiffany M. CarrSara J. AdairKevin T. Hogan Original Article 20 June 2007 Pages: 31 - 42
A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells P. BühlerP. WolfU. Elsässer-Beile Original Article Open access 20 June 2007 Pages: 43 - 52
HLA-DPB1 supertype-associated protection from childhood leukaemia: relationship to leukaemia karyotype and implications for prevention Malcolm TaylorChristine Harrisonon behalf of UKCCS Investigators Original Article 12 July 2007 Pages: 53 - 61
Activation and route of administration both determine the ability of bone marrow-derived dendritic cells to accumulate in secondary lymphoid organs and prime CD8+ T cells against tumors Stephanie P. HuckShiau-Choot TangFranca Ronchese Original Article 03 July 2007 Pages: 63 - 71
Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation Atsuko FujiharaMasayuki KurookaYasufumi Kaneda Original Article 30 June 2007 Pages: 73 - 84
Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue David SchramaHeike VoigtJürgen C. Becker Original Article 29 June 2007 Pages: 85 - 95
Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma Femke HillenCoen I. M. BaetenArjan W. Griffioen Original Article 30 June 2007 Pages: 97 - 106
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development Jovanny ZabaletaBarbara G. SchneiderAugusto C. Ochoa Original Article 06 July 2007 Pages: 107 - 114
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells Hidenobu OchiaiGary E. ArcherJohn H. Sampson Original Article 19 July 2007 Pages: 115 - 121
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy Justin T. JordanWei SunAmy B. Heimberger Original Article 24 May 2007 Pages: 123 - 131
Preferential migration of regulatory T cells mediated by gliomasecreted chemokines can be blocked with chemotherapy Justin T. JordanWei SunAmy B. Heimberger Erratum 20 September 2007 Pages: 133 - 133
Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12–14, 2007 in Würzburg, Germany Marij J. P. WeltersCécile GouttefangeasCedrik M. Britten Meeting Report Open access 06 October 2007 Pages: 135 - 142